1. Braquet, P., L. Touqui, T. Y. Shen, B. B. Vargaftig. 1987. Perspectives in platelet-activating factor research.Pharmacol. Rev. 39:97?145.
2. Shaw, J. O., R. N. Pinckard, K. S. Ferrigni, L. M. McManus, andD. J. Hanahan. 1981. Activation of human neutrophils with l-o-hexadecyl/octodecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet-activating factor).J. Immunol. 127:1250?1255.
3. Tonnesen, M. G., D. C. Anderson, T. A. Springer, A. Knedler, N. Avdi, andP. M. Henson. 1989. Adherence of neutrophils to cultured human microvascular endothelial cells. Stimulation by chemotactic peptides and lipid mediators and dependence upon the Mac-1, LFA-1, p150,95 glycoprotein family.J. Clin. Invest. 83:637?646.
4. Bussolino, F., G. Camusi, M. Aglietta, P. Braquet, A. Bosia, G. Pescarmona, F. San-Avio, N. D'urso, andP. C. Marchisio. 1987. Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures.J. Immumol. 139:2439?2446.
5. Burhop, K. E., J. G. N. Garcia, W. M. Selig, S. K. Lo, H. Zee, J. E. Kaplan, andA. B. Malik. 1986. Platelet-activating factor increases lung vascular permeability to protein.J. Appl. Physiol. 61:2210?2217.